Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Aerucin/kg · 1 trial · 1 indication
Number and % of subjects experiencing adverse events following dosing
Number and % of subjects experiencing Serious Adverse Events following dosing
Number and % of subjects experiencing Solicited Adverse Events following dosing
| Arm | Type | Description |
|---|---|---|
| Group 1 | EXPERIMENTAL | Aerucin 2.0mg/kg |
| Group 2 | EXPERIMENTAL | Aerucin 8.0mg/kg |
| Group 3 | EXPERIMENTAL | Aerucin 20.0mg/kg |
| Name | Type | Description |
|---|---|---|
| Aerucin 2.0mg/kg | BIOLOGICAL | IV Aerucin 2.0 mg/kg over 1 hour |
| Aerucin 8.0mg/kg | BIOLOGICAL | IV Aerucin 8.0 mg/kg over 1 hour |
| Aerucin 20.0 mg/kg | BIOLOGICAL | IV Aerucin 20 mg/kg over 1 hour |
Inclusion Criteria: 1. Has completed the written informed consent process 2. Is male or female 3. Is age ≥18 years and ≤50 years 4. Agrees to stay in contact with the study site for the duration of the study, provide updated contact information as necessary, and has no current plans to move from th...